Dr. Yousef Ismael, MD

Dr. Ismael practices at Ottumwa Regional Health Center in Ottumwa, Iowa, part of Lifepoint Health.

Dr. Ismael's NPI, 1922657337, was assigned on September 9, 2019. Dr. Ismael holds Iowa license SP-0237.

Dr. Ismael's primary practice is Ottumwa Regional Health Center, at 1001 E Pennsylvania, Ottumwa, IA 52501 in Wapello County. The practice phone is (641) 682-7511.

Dr. Ismael's primary practice is Ottumwa Regional Health Center in Ottumwa, Iowa, part of Lifepoint Health. Dr. Ismael is also affiliated with Pella Regional Health Center. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Ismael to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ismael practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ismael's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ismael is licensed in Iowa.

CMS data shows 1,165 Medicare services from Dr. Ismael across 14 procedure codes in 2024, for 127 Medicare patients. Medicare paid $96,741 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Ismael in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ismael's median patient age at 74, with 33% women.

In 2024, Dr. Ismael wrote 132 Medicare Part D claims for 57 patients. 89% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $495 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Ismael for performance year 2024, reported as part of a group. Dr. Ismael accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Ismael, published from 2010 to 2022. 2011 was the busiest year, with 3. The most frequent topics are Craniopharyngioma, Pituitary Neoplasms and Proton Therapy. Dr. Ismael has published most often in Int J Radiat Oncol Biol Phys. Dr. Ismael's most frequent co-authors are Daniel J. Indelicato, MD, Lucas Elijovich, MD and Emad Hammode.

CMS Open Payments shows 1 general payment to Dr. Ismael from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Tactile Systems Technology Inc paid the most, $18.